Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Remote monitoring of fetal health in high-risk pregnancies

Official title: Investigating the Acceptability and Feasibility of Remote Fetal Monitoring in a High Risk Obstetric Population

Run by Beth Israel Deaconess Medical Center · NCT06822439 · Data updated 2026-11-12

This study is testing if women with high-risk pregnancies can safely monitor their baby's heart rate at home using a special device to see if it helps improve their care.

More Diabetes trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment50 (estimated)
SponsorBeth Israel Deaconess Medical Center
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedMay 1, 2025
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedMarch 9, 2026
Trial IDNCT06822439 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking women with intrauterine pregnancies greater than 32 weeks gestation who are recommended for weekly antenatal fetal testing.

Probably not a fit

Patients under 18 years old or non-English speakers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study evaluates the feasibility and acceptability of conducting nonstress tests (NSTs) at home for women with high-risk pregnancies. Participants will use a non-invasive fetal electrocardiography device to monitor fetal heart rate three times a week starting at 32 weeks of gestation. The goal is to determine if this home monitoring can supplement routine prenatal care and alleviate the burden on healthcare providers. The study aims to address access to care issues and improve the management of high-risk pregnancies.

Why it matters

Potential benefit: If successful, this approach could enhance prenatal care accessibility and improve fetal monitoring for women with high-risk pregnancies.

How similar studies have gone: While non-invasive fetal monitoring has been primarily limited to research, there is potential for success based on advancements in technology and previous studies exploring remote monitoring.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Intrauterine pregnancy greater than 32 weeks gestation
* Recommended for at least once weekly antenatal fetal testing by their obstetrician
* English-speaking

Exclusion Criteria:

* Under age 18 years of old
* Non-english speaking

Where it's running

  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.